ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
Conference call scheduled for November 6, 2008 at 1:30 p.m. (Pacific); simultaneous webcast at www.adventrx.com
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX) today announced that it will host a conference call with
simultaneous webcast to discuss third quarter 2008 results on Thursday,
November 6th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Mark N. K.
Bagnall, Executive Vice President and Chief Financial Officer, is scheduled to
lead the call and will be joined by other members of the Company's senior
management.
The conference call may be accessed by dialing (866) 550-6338 for domestic
callers and (347) 284-6930 for international callers, and entering the pass
code 1669546. The webcast will be available live via the Internet by accessing
ADVENTRX's website at http://www.adventrx.com under "Investors". Replays of
the webcast will be available on ADVENTRX's website for 30 days and a phone
replay will be available through November 11th, 2008 by dialing (888) 203-1112
and entering the pass code 1669546.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on
in-licensing, developing and commercializing proprietary product candidates
primarily for the treatment of cancer. The Company seeks to improve the
performance and commercial potential of existing treatments by addressing
problems associated with these treatment regimens. More information can be
found on ADVENTRX's web site at http://www.adventrx.com.
